Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02142868 |
Title | Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate |
Recruitment | No longer available |
Gender | female |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | CAN |